Hormone Receptor Negative Tumor clinical trials at UCSF

1 research study open to eligible people

A hormone receptor negative tumor does not rely on hormones to grow. UCSF is conducting research to test new treatments for breast cancer with these tumors. These trials are part of efforts to improve patient care.

Showing trials for

  • I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

    open to eligible people ages 18 years and up

    The purpose of this study is to further advance the ability to practice personalized medicine by learning which new drug agents are most effective with which types of breast cancer tumors and by learning more about which early indicators of response (tumor analysis prior to surgery via magnetic resonance imaging (MRI) images along with tissue and blood samples) are predictors of treatment success.

    San Francisco, California and other locations

Last updated: